Collaborative implementation of stereotactic ablative body radiotherapy: A model for the safe implementation of complex radiotherapy techniques in Australia

• Published in: Asia-Pacific journal of clinical oncology 2020-02, Vol.16 (1), p.39-44
• Main Authors: Hau, Eric, Hegi‐Johnson, Fiona, Atkinson, Charlotte, Barber, Jeffrey, Browne, Lois H, Chin, Yaw, Dwyer, Patrick, Graham, Peter H, O'Hare, Jolyne, Lu, Dan, Rains, Melissa, Ragusa, Carolina, Schmidth, Laurel, Small, Katherine, Unicomb, Kylie, West, Katrina, White, Sean, Last, Andrew, Ludbrook, Jane, Azzi, Maria, Aherne, Noel J, Van Tilburg, Kevin, Vinod, Shalini, Ma, Xiaobing, Yeghiaian Alvandi, Roland
• Format: Article
• Language: English
• Subjects: Aged; Australia; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Non-Small-Cell Lung - surgery; Collaboration; Dose Fractionation, Radiation; Female; Geriatrics; Health Plan Implementation; Humans; Lung cancer; Lung Neoplasms - pathology; Lung Neoplasms - surgery; Male; Models, Theoretical; Non-small cell lung carcinoma; Prognosis; Quality of Life; radiation; Radiation therapy; Radiosurgery - methods; radiotherapy; Small cell lung carcinoma; stereotactic; stereotactic body; Toxicity
• ISSN: 1743-7555; 1743-7563
• DOI: 10.1111/ajco.13277

Introduction Stereotactic ablative radiotherapy (SABR) for lung cancer is a modality of treatment that has improved outcomes for lung cancer patients. However, radiotherapy for lung cancer is underutilized and fewer than half of elderly patients with non‐small cell lung cancer (NSCLC) receive active treatment. The purpose of this study is to report on a collaboration in implementing an NSCLC SABR (stereotactic ablative body radiation) program safely, efficiently, and uniformly across several centers, including regional sites. The first aim of this paper is to detail the collaboration and implementation that started in 2013 and is ongoing. The second aim of this paper is to document early toxicities and quality of life outcomes. Method A tripartite approach was used to develop the protocol and networks required for the implementation of SABR across multiple sites in NSW. Departments starting the programmes were supported and physics credentialing with central site submission was required before commencing the treatment. Additional ongoing support was available via an email discussion group involving all members of the collaboration. Results Between July 22, 2013 and February 22, 2016, 41 patients were enrolled with 34 patients in active follow up. The toxicity profile so far is similar to those of published studies with no appreciable effect on quality of life outcomes. Conclusion The collaboration formed an effective framework in facilitating the implementation of SABR across several sites in NSW and could be used as a model for the safe and uniform implementation of new technologies in Australia.